kynurenine has been researched along with Weight Gain in 8 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The hyperglycemia was accompanied with decreased insulin levels, which may have been due to the repression of genes involved in insulin secretion." | 5.62 | Kynurenine-Induced Aryl Hydrocarbon Receptor Signaling in Mice Causes Body Mass Gain, Liver Steatosis, and Hyperglycemia. ( Chamberlin, MD; Coker, S; Lewis, LD; Moyer, BJ; Ness, DB; Pooler, DB; Ringelberg, CS; Rojas, IY; Tomlinson, CR; Tosteson, TD; Wilkins, OM, 2021) |
| " We propose urinary levels of 3-hydroxykynurenine/3-hydroxyanthranilic acid to be surrogate indicators for predicting the adverse effects of D-tryptophan from the break point of body-weight gains and urinary levels of D-tryptophan metabolites." | 3.80 | The urinary ratio of 3-hydroxykynurenine/3-hydroxyanthranilic acid is an index to predicting the adverse effects of D-tryptophan in rats. ( Fukuwatari, T; Ohno, T; Sano, M; Shibata, K, 2014) |
| "The hyperglycemia was accompanied with decreased insulin levels, which may have been due to the repression of genes involved in insulin secretion." | 1.62 | Kynurenine-Induced Aryl Hydrocarbon Receptor Signaling in Mice Causes Body Mass Gain, Liver Steatosis, and Hyperglycemia. ( Chamberlin, MD; Coker, S; Lewis, LD; Moyer, BJ; Ness, DB; Pooler, DB; Ringelberg, CS; Rojas, IY; Tomlinson, CR; Tosteson, TD; Wilkins, OM, 2021) |
| "In this study, the effects of lung inflammation, induced by the intravenous injection of complete Freund's adjuvant, and dietary Trp content on Trp metabolism and availability were investigated." | 1.35 | Dietary tryptophan helps to preserve tryptophan homeostasis in pigs suffering from lung inflammation. ( Le Floc'h, N; Melchior, D; Sève, B, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Oxenkrug, G | 1 |
| Summergrad, P | 1 |
| Rojas, IY | 1 |
| Moyer, BJ | 1 |
| Ringelberg, CS | 1 |
| Wilkins, OM | 1 |
| Pooler, DB | 1 |
| Ness, DB | 1 |
| Coker, S | 1 |
| Tosteson, TD | 1 |
| Lewis, LD | 1 |
| Chamberlin, MD | 1 |
| Tomlinson, CR | 1 |
| Lenski, M | 1 |
| Sidibé, J | 1 |
| Gholam, M | 1 |
| Hennart, B | 1 |
| Dubath, C | 1 |
| Augsburger, M | 1 |
| von Gunten, A | 1 |
| Conus, P | 1 |
| Allorge, D | 1 |
| Thomas, A | 1 |
| Eap, CB | 1 |
| Gibney, SM | 1 |
| Fagan, EM | 1 |
| Waldron, AM | 1 |
| O'Byrne, J | 1 |
| Connor, TJ | 1 |
| Harkin, A | 1 |
| Shibata, K | 1 |
| Ohno, T | 1 |
| Sano, M | 1 |
| Fukuwatari, T | 1 |
| da Silva Dias, IC | 1 |
| Carabelli, B | 1 |
| Ishii, DK | 1 |
| de Morais, H | 1 |
| de Carvalho, MC | 1 |
| Rizzo de Souza, LE | 1 |
| Zanata, SM | 1 |
| Brandão, ML | 1 |
| Cunha, TM | 1 |
| Ferraz, AC | 1 |
| Cunha, JM | 1 |
| Zanoveli, JM | 1 |
| Le Floc'h, N | 1 |
| Melchior, D | 1 |
| Sève, B | 1 |
| Ronen, N | 1 |
| Gross, B | 1 |
| Ben-Shachar, D | 1 |
| Livne, E | 1 |
8 other studies available for kynurenine and Weight Gain
| Article | Year |
|---|---|
Benserazide, an Inhibitor of Peripheral Kynurenine Metabolism, Attenuates Olanzapine-Induced Weight Gain, Insulin Resistance, and Dyslipidemia in C57Bl/6j Mice.
Topics: Animals; Antipsychotic Agents; Benserazide; Dyslipidemias; Female; Insulin Resistance; Kynurenine; M | 2020 |
Kynurenine-Induced Aryl Hydrocarbon Receptor Signaling in Mice Causes Body Mass Gain, Liver Steatosis, and Hyperglycemia.
Topics: Animals; Fatty Liver; Hyperglycemia; Kynurenine; Liver; Mice; Receptors, Aryl Hydrocarbon; Signal Tr | 2021 |
Metabolomic alteration induced by psychotropic drugs: Short-term metabolite profile as a predictor of weight gain evolution.
Topics: Adult; Aged; Biomarkers; Cohort Studies; Female; Humans; Kynurenine; Male; Metabolomics; Middle Aged | 2021 |
Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour.
Topics: Allopurinol; Animals; Antidepressive Agents; Cerebral Cortex; Chronic Disease; Corticosterone; Depre | 2014 |
The urinary ratio of 3-hydroxykynurenine/3-hydroxyanthranilic acid is an index to predicting the adverse effects of D-tryptophan in rats.
Topics: 3-Hydroxyanthranilic Acid; Amino Acid Metabolism, Inborn Errors; Animals; Diet; Hydrolases; Kynureni | 2014 |
Indoleamine-2,3-Dioxygenase/Kynurenine Pathway as a Potential Pharmacological Target to Treat Depression Associated with Diabetes.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Blood Glucose; Cytokines; Depression; Diabetes Mel | 2016 |
Dietary tryptophan helps to preserve tryptophan homeostasis in pigs suffering from lung inflammation.
Topics: Animals; Antioxidants; Diet; Dietary Supplements; Female; Haptoglobins; Homeostasis; Kynurenine; Mal | 2008 |
The effects of induced kynurenine pathway on immunocytochemical changes in rat tissues following excessive L-tryptophan consumption.
Topics: Animals; Brain; Female; Fenclonine; Food, Fortified; Immunohistochemistry; Kynurenine; Lung; Muscle, | 1996 |